Market Overview

UPDATE: Goldman Sachs Initiates Align Technology at Neutral; Near-Term Visibility Lacking

Share:
Related ALGN
Benzinga's Top Initiations
Medical Device Co. Align Technology Has Clear Upside, Says Leerink
Align Technology and 'Shape Announce New Workflow Integration Including Trios Scanner ... (GuruFocus)

Goldman Sachs initiated coverage on Align Technology (NASDAQ: ALGN) with a Neutral rating and a $28 price target.

Goldman Sachs noted, "Our proprietary survey of 100 US GPs/Orthodontists supports our long-term view that Align is well positioned to leverage its dominant market share in a significantly underpenetrated space, where we model a 2012-2015 case CAGR of 15%. That said, Align's 3Q miss (first sales miss in five years) and negative 4Q preannouncement, which came with management departures, have introduced near-term uncertainty. From here, we would need to see a reacceleration in growth before we become more positive."

Align Technology closed at $26.20 on Monday.

Latest Ratings for ALGN

DateFirmActionFromTo
Mar 2016Roth CapitalMaintainsBuy
Nov 2015Piper JaffrayInitiates Coverage onOverweight
Oct 2015JefferiesMaintainsBuy

View More Analyst Ratings for ALGN
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (ALGN)

View Comments and Join the Discussion!